Orthopediatrics (KIDS) Hits New 52-Week High at $47.82

Orthopediatrics Corp (NASDAQ:KIDS)’s share price hit a new 52-week high on Thursday . The company traded as high as $47.82 and last traded at $45.94, with a volume of 5203 shares. The stock had previously closed at $46.66.

KIDS has been the subject of a number of recent research reports. Zacks Investment Research downgraded shares of Orthopediatrics from a “buy” rating to a “hold” rating in a research note on Friday, March 15th. BidaskClub raised shares of Orthopediatrics from a “hold” rating to a “buy” rating in a research note on Thursday, December 20th. BTIG Research boosted their price target on shares of Orthopediatrics to $44.00 and gave the stock a “buy” rating in a research note on Friday, March 8th. Finally, JMP Securities initiated coverage on shares of Orthopediatrics in a research note on Wednesday, February 20th. They set an “outperform” rating and a $44.00 price target for the company. Six analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The company presently has an average rating of “Buy” and a consensus price target of $41.00.

The company has a market capitalization of $687.63 million, a price-to-earnings ratio of -48.49 and a beta of 0.18. The company has a debt-to-equity ratio of 0.26, a quick ratio of 7.77 and a current ratio of 10.54.

Orthopediatrics (NASDAQ:KIDS) last issued its quarterly earnings data on Wednesday, March 6th. The company reported ($0.19) earnings per share (EPS) for the quarter, meeting the Zacks’ consensus estimate of ($0.19). The firm had revenue of $14.60 million during the quarter, compared to analysts’ expectations of $14.50 million. Orthopediatrics had a negative net margin of 20.89% and a negative return on equity of 22.99%. The business’s revenue for the quarter was up 24.8% on a year-over-year basis. During the same quarter in the previous year, the company earned ($1.41) earnings per share. Equities analysts anticipate that Orthopediatrics Corp will post -0.41 EPS for the current fiscal year.

A number of institutional investors and hedge funds have recently made changes to their positions in KIDS. Northern Trust Corp boosted its holdings in Orthopediatrics by 64.0% during the second quarter. Northern Trust Corp now owns 88,863 shares of the company’s stock worth $2,367,000 after purchasing an additional 34,687 shares during the last quarter. JPMorgan Chase & Co. raised its position in Orthopediatrics by 20.5% during the third quarter. JPMorgan Chase & Co. now owns 70,225 shares of the company’s stock worth $2,573,000 after acquiring an additional 11,931 shares in the last quarter. Rhumbline Advisers bought a new stake in Orthopediatrics during the third quarter worth $207,000. EAM Investors LLC raised its position in shares of Orthopediatrics by 118.8% in the third quarter. EAM Investors LLC now owns 68,217 shares of the company’s stock valued at $2,499,000 after purchasing an additional 37,045 shares during the period. Finally, PNC Financial Services Group Inc. bought a new position in Orthopediatrics during the third quarter worth about $448,000. Institutional investors and hedge funds own 45.14% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: This news story was first reported by Sports Perspectives and is owned by of Sports Perspectives. If you are reading this news story on another site, it was copied illegally and reposted in violation of US and international trademark and copyright law. The correct version of this news story can be viewed at https://sportsperspectives.com/2019/03/21/orthopediatrics-kids-hits-new-52-week-high-at-47-82.html.

Orthopediatrics Company Profile (NASDAQ:KIDS)

OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company's products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail products, PediLoc tibia products, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, RESPONSE Spine systems, Bandloc, and Pediguard.

See Also: How to invest in blue-chip stocks

Receive News & Ratings for Orthopediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthopediatrics and related companies with MarketBeat.com's FREE daily email newsletter.